New study uses AlphaFold and AI to accelerate design of novel drug for liver cancer
New research uses AlphaFold, an artificial intelligence (AI)-powered protein structure database, to accelerate the design…
New research uses AlphaFold, an artificial intelligence (AI)-powered protein structure database, to accelerate the design…
Professor Wenbiao Hu from the QUT School of Public Health and Social Work said the…
The most common type of liver cancer, hepatocellular carcinoma (HCC), is already the third leading…
Research led by Randal J. Kaufman, Ph.D., has found that misfolded proteins in liver cells contribute…
A new analysis reveals that primary liver cancer was among the top three causes of…
Ground-breaking research that is improving screening and diagnoses for liver cancer has earned Associate Professor…
Physicians and researchers from UK HealthCare’s Transplant Center and the University of Kentucky Markey Cancer Center, USA, conducted a…
Liver cancer’s rapid growth leads to a vulnerability in its energy-production and cell-building processes that…
The primary causes of liver cancer are well known: viral (hepatitis B and C), alcohol…
Until recently, nearly all pediatric liver cancers were classified as either hepatoblastoma or hepatocellular carcinoma.…